150 related articles for article (PubMed ID: 8039321)
1. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
Shapiro B; Grekin R; Gross MD; Freitas JE
Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321
[TBL] [Abstract][Full Text] [Related]
2. Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.
Hwang I; Chong A; Kim JB; Kim KH; Kwon D
Korean J Urol; 2014 Aug; 55(8):551-3. PubMed ID: 25132951
[No Abstract] [Full Text] [Related]
3. Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction.
Gianchandani RY; Quin GA; Grekin RJ; Gross MD; Sisson JC; Thompson NW; Shapiro B
J Nucl Med; 1996 May; 37(5):852-4. PubMed ID: 8965160
[TBL] [Abstract][Full Text] [Related]
4. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.
Fischer M; Vetter W; Winterg B; Zidek W; Vetter H
Eur J Nucl Med; 1982; 7(5):222-4. PubMed ID: 7094925
[TBL] [Abstract][Full Text] [Related]
5. [An abdominal CT scan in first-line is an efficient investigation of uncontrolled hypertensives suspected to have an adrenal cause].
Rosenbaum D; Rigabert J; Villeneuve F; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):209-12. PubMed ID: 22748398
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Ladurner R; Sommerey S; Buechner S; Dietz A; Degenhart C; Hallfeldt K; Gallwas J
Eur J Clin Invest; 2017 May; 47(5):372-377. PubMed ID: 28299775
[TBL] [Abstract][Full Text] [Related]
7. Adrenal scintigraphy in low renin essential hypertension.
Rifai A; Beierwaltes WH; Freitas JE; Grekin R
Clin Nucl Med; 1978 Jul; 3(7):282-6. PubMed ID: 709982
[TBL] [Abstract][Full Text] [Related]
8. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict
Lu CC; Yen RF; Peng KY; Huang JY; Wu KD; Chueh JS; Lin WY
Front Endocrinol (Lausanne); 2021; 12():644927. PubMed ID: 33995277
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphy of incidentally discovered bilateral adrenal masses.
Gross MD; Shapiro B; Francis IR; Bree RL; Korobkin M; McLeod MK; Thompson NW; Sanfield JA
Eur J Nucl Med; 1995 Apr; 22(4):315-21. PubMed ID: 7607261
[TBL] [Abstract][Full Text] [Related]
10. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
[TBL] [Abstract][Full Text] [Related]
11. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I
Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137
[TBL] [Abstract][Full Text] [Related]
12. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
[TBL] [Abstract][Full Text] [Related]
13. A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations.
Carroll R; Gould A; Feltham J; Harper S
N Z Med J; 2017 May; 130(1455):129-132. PubMed ID: 28494487
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
15. False localization of an aldosteronoma by dexamethasone-suppressed adrenal scintigraphy.
Herd GW; Semple PF; Parker D; Davidson JK; Hilditch TE; Fraser R
Clin Endocrinol (Oxf); 1987 Jun; 26(6):699-705. PubMed ID: 3665124
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls in the diagnostics of aldosterone-producing adrenocortical carcinoma.
Łebek-Szatańska A; Nowak KM; Papierska L
Endokrynol Pol; 2020; 71(6):575-576. PubMed ID: 32944927
[TBL] [Abstract][Full Text] [Related]
17. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
[TBL] [Abstract][Full Text] [Related]
18. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
Sialer G; Marincek B; Mengden T; Vetter W
Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
[TBL] [Abstract][Full Text] [Related]
19. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning.
Mansoor GA; Malchoff CD; Arici MH; Karimeddini MK; Whalen GF
Am J Hypertens; 2002 May; 15(5):459-64. PubMed ID: 12022249
[TBL] [Abstract][Full Text] [Related]
20. Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan.
Hollak CE; Prummel MF; Tiel-van Buul MM
J Intern Med; 1991 Jun; 229(6):545-8. PubMed ID: 2045765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
